Guangzhou Wondfo Biotech Co., LtdS1.G19Founded in 1992, headquartered in Guangzhou science city, Wondfo focuses on the R&D, manufacturing, sales and service of IVD (In Vitro diagnostics) industry, providing professional rapid diagnosis and chronic disease management solutions.
Wondfo has 9 technology platforms. Our rapid diagnostic devices and reagents span a wide spectrum, including cardiovascular diseases, diabetes, renal functions, respiratory issues, fertility, DOA, infections, tumor etc. We provide service to over 150 countries and regions.
In 2015, Wondfo was listed on Shenzhen Stock Exchange, becoming the first public company in POCT in China.
